These pilot projects are intended to support a wide range of biomedical research, including fundamental basic science, clinical/translational science, health policy, social science, digital health (incorporating the use of mobile technology) and population science.

Pilot projects are for one year and not renewable. (Some funding agencies allow for no-cost extensions. This will be clarified in the Award Letter.) Pilot research should collect data for publications and to acquire successful subsequent funding by other mechanisms. All funding agencies require progress reports if an award is received. The number and timing of those reports varies between the agencies. Detailed information about this will appear in the respective funding agencies' Award Letter.

For projects focusing on Digital Health Research

Funds are available for research-focused projects in mobile health (dHealth), defined as the use of mobile technology in conjunction with Internet and social media to improve health and wellness and/or to manage disease. dHealth emphasizes use by laypeople but also includes use by clinicians and other health care workers (including public health and community care workers). Awards can be for projects in any health domain where there exists an unmet need or the potential for significant improvement over current approaches.

Projects are encouraged that involve delivery of the technology over mobile devices (mobile phones, tablets, excluding laptops). Examples include mobile phone "apps" for medication reminders, symptom tracking, improved dietary habits, health records exchange, or medical reference. Note that feasibility studies determining the potential value of a dHealth intervention that do not in themselves use or propose to develop a specific technology (e.g., evaluation of technology access in a target group, focus groups/interviews to determine barriers to potential adoption of dHealth interventions) are appropriate.

Eligibility requirements need to be met as of date of submission; no waivers are allowed.

Who's Eligible:UCSF Faculty in any Series (Ladder Rank, In Residence, Clinical X, Health Science Clinical, Adjunct) in the ranks of Associate Professor and Full Professor can apply. Appointees to the Professional Research Series at the ranks of Associate Research and Research (full) can also apply. Appointees to the Librarian Series may apply.If the proposal has multiple PIs, both PI1 and PI2 need to meet the eligibility criteria listed above for this grant mechanism (both PI1 and PI2 need to be Associate and/or Full Prof.)

PREMIER is an NIH/NIAMS funded Center at UCSF with the overarching goal of facilitating and enhancing precision medicine studies in rheumatic and autoimmune diseases. All applicants seeking funding through PREMIER for pilot grants must be members of the Center. All UCSF faculty are eligible for membership; please apply through the PREMIER website http://premier.ucsf.edu/. Established investigators should clearly address in their proposal:

1) How the project is expected to advance precision medicine in rheumatic or autoimmune disease.

2) How the project differs from or extends your ongoing research.

These grants are intended for projects that are translational in nature with studies focused on advancing precision medicine in rheumatology. Projects related to all types of rheumatologic and/or human autoimmune diseases will be considered. Projects should utilize human samples or show direct links to rheumatologic/autoimmune disease in humans. PREMIER consists of 3 Resource Cores (HSCP: Human Studies and Clinical Phenotyping, GMR: Genomics and Molecular Resources, and IB: Integrative Bioinformatics). You must use a portion of your funds in at least one of the Cores (HSCP: Human Studies and Clinical Phenotyping, GMR: Genomics and Molecular Resources, and IB: Integrative Bioinformatics), although use in more than one Core is encouraged. For more information on our Cores, PREMIER and how to apply for membership, please see our web site at http://premier.ucsf.edu/. For projects focused on Rheumatoid Arthritis you may also consider applying for BPRAR pilot grants. We encourage all applicants to contact us at premier@ucsf.edu. Center personnel can assist with preparation of your proposal.

BPRAR seeks to stimulate and support highly innovative basic science research focused on advancing our understanding and treatment of rheumatoid arthritis. These grants will provide pilot funding to develop basic science projects that are creative and have potential for high impact. High risk, novel and potentially transformative projects are encouraged! Applicants should explicitly address issues of innovation, risk and impact in their proposal in addition to the relevance to Rheumatoid Arthritis.Projects involving human samples are encouraged to partner with the PREMIER center cores to facilitate sample acquisition (http://premier.ucsf.edu or contact premier@ucsf.edu).

A proposal MUST have a SOD PI and at least one SOD collaborator in another department within the School of Dentistry or another discipline if the collaborator is in the same SOD department. This is a mandatory requirement. Proposals that involve collaboration between a basic researcher and a clinical researcher (specifically NOT between two clinician-researchers, unless they form a new team from fundamentally different disciplines) are encouraged but not required.

In addition to two SOD PIs, proposals including School of Medicine, School of Nursing or School of Pharmacy collaborators are welcomed.

Core Center for Musculoskeletal Biology and Medicine (CCMBM)Applicants must be FULL members of the Center. Instructions for becoming a member can be found at Women's Wedge Clea Black Anna Capri Tq5gx0. In addition, established investigators should explicitly indicate how the proposed work:

tests the feasibility of a new or innovative idea related to musculoskeletal disease representing a clear and distinct departure from their ongoing research; B. addresses a problem in musculoskeletal field, and that the PI is new to this field.

In the body of the RAP application, please address your membership status and how you fulfill either of these proposal criteria. We will accept new members as late as September 10, 2018.

The CCMBM Pilot/Feasibility grants are intended for projects that are translational in nature and related to musculoskeletal disease. Digital health projects in this area will also be accepted. The CCMBM consists of 3 Research Cores (Imaging, Epidemiology & Biostatistics, and Skeletal Biology). You must use a portion of your funds in, at least, one of the cores although use in more than one core is encouraged. For more information on our Cores and the CCMBM in general, please see our web site.

Cancer Center- CCSG Developmental Funds (funded by the NCI P30 award), applicants must be Cancer Center Members or Associate Members. If the proposal has multiple PIs, both PI1 and PI2 need to meet the eligibility criteria listed above for this grant mechanism. This program provides seed funding to encourage innovative cancer-related research in a wide range of research areas, including basic science, clinical and translational science, health policy and social science, and population sciences. Priority is given to translational science and to areas that are generally under-represented, such as population sciences. This program supports novel cancer research initiatives which are not currently funded by research grants and which may ultimately lead to new ways of preventing, detecting or treating cancer. Emphasis is placed on innovative projects, and applicants must be a Cancer Center Member or Associate Member. Training costs and routine equipment purchases are not allowable. International Subcontracts are allowable on CCSG funds, with specific requirements regarding foreign components and if the foreign subcontractor is from industries (see Detailed Budget section below).

Naperville Gold SoftWalk Wash Women's Naperville Women's SoftWalk Cancer Center-MZHF (funded by the Mt. Zion Health Fund) provides seed funding to encourage clinical and clinical translational scientists, especially those at the beginning of their research career or established investigators wishing to embark on a new area of study, to initiate promising new projects in cancer research that may enable them to compete successfully for federal research grants. Targeted areas are innovative pilot, phase I/II therapeutic studies and other projects in clinical, health policy, health services, psychosocial and behavioral research that have direct application to the prevention, diagnosis, and treatment of cancer. Pre-clinical or laboratory correlative studies that demonstrate a direct path to the clinic will also be considered. The proposed project must be a Mt. Zion-based activity; or led primarily by Mt. Zion-based personnel; or use a Mt. Zion-based resource; or that will especially benefit Mt. Zion constituents (e.g., patients, families, faculty, staff, and/or trainees). Applicants must be physician-scientists and a Cancer Center member or be sponsored by a Cancer Center member. Investigators who are proposing basic science and population research projects are eligible for funding through the Academic Senate, REAC, and CTSI-Pilot Awards.

Research Evaluation and Allocation Committee (REAC) applicants must have an appointment with UCSF and School of Medicine. REAC funds pilot projects ranging from basic to clinical and translational. Pilot research should collect data for publication and to acquire successful subsequent funding by other mechanisms.

Research that incorporates methods and approaches of particular relevance to children, the elderly, or socially or medically vulnerable populations, with preference for projects focused on developing or advancing critical measurement domains that span all three populations - function and cognition, caregiver burden and context, family dynamics and social support, poverty, and health literacy; or

Mobile health, specifically projects involving delivery of the technology over mobile devices and culminating in the generation of new knowledge on digital health methods, efficacy, effectiveness, or policy.

Criteria for Review/Evaluation of Applications Projects will be evaluated based on the quality of the proposed scientific investigation, the potential of the proposal to lead to a fully funded independent research grant, and the quality and potential of the applicant and the research team. Consideration will also be given to documented need for the funds based on review of investigator's biosketch and other relevant information.

Selection of Awardees Funding decisions are made independently by each funding agency based on several factors – scientific review score, alignment of proposal to funder’s strategic goals, proposal research area of focus, and specifically called out eligibility or other requirements like membership in a center, affiliation with a specific school or relevance to a stated auxiliary topic.

ResubmissionsWash Women's Gold Women's Naperville SoftWalk SoftWalk Naperville Definition: same research topic with an amended application or research plan rather than a new research topic and new research plan.Requirements: Please use up to one extra page to introduce your revised proposal, addressing the issues raised in the review, and any additional changes to your proposal. A new letter from the Chair is not required if the resubmission is within 2 cycles (one skipped cycle max). You will include the old letter and state your resubmission is within 2 cycles and new letter is not required. Make sure the new changes are highlighted in bold or italic font so the reviewers can easily see where and how the proposal has changed. Do not use track changes.

1. P.I. Name(s) - Optionally, you may apply with two PIs. If funded, PI1 will be the primary contact for the award set up and management. If the proposal has multiple PIs, both PI1 and PI2 need to meet the eligibility criteria listed for this grant mechanism (both PI1 and PI2 need to be Associate and/or Professor). Only one application as PI (PI1 OR PI2) is permitted per cycle.

*NIH base salary cap. Fully justify all requests. Generally PI partial salary support should not exceed 10% of the budget, salaries over 10% must be well justified. Multiple PIs can decide how to distribute the 10% salary support amongst themselves (e.g., 5%/5% or 6%/4%).

** If CCSG resources are used in partnership with industrial resources, the Cancer Center must assure that applicable federal law governs the public availability of any final products of the research. In addition, NIH must track all pilot projects in this category that include foreign components and, if necessary, State Department clearance must be obtained prior to implementation. Cancer Center staff will act as the liaison between the Centers and the NIH Fogarty International Center, which is responsible for coordinating all clearances.

PREMIER cannot fund any international projects or expenses. You mustTaupe Sandal Women's Haflinger Haflinger Pansy Women's KMF4af use a portion of your funds in at least one of the Cores (HSCP: Human Studies and Clinical Phenotyping, GMR: Genomics and Molecular Resources, and IB: Integrative Bioinformatics), although use in more than one Core is encouraged. In the budget, you will need to outline how funds will be spent in Core(s). To obtain an estimate regarding Core usage, please use the request services form on the PREMIER website (http://premier.ucsf.edu/content/request-services) and enter RAP grant proposal in your request. IACUC and IRB approvals letters, and evidence of human studies training (if applicable) need to be provided for timely release of project funds.

CCMBM cannot fund any international projects or expenses. In the budget, please also outline how much money you will be spending in each CCMBM core. In addition, before the CCMBM can release funds, NIH/NIAMS requires a review of the application to ensure all relevant human and animal welfare protocols are approved and in place. Consequently, proof of relevant training for all PIs and Co-Is (if applicable) and IACUC and IRB approvals letters (if applicable) need to be provided for timely release of project funds.

Use this version: Shellys Women's Boot Cobalt Robi London Multi rOBwq7rx5n. Include biosketches for all PIs of a multi-PI application, and any other key personnel such as Co-Investigator(s) or UCSF Faculty Mentor(s). In section "D. Additional Information", list the relevant recent past, planned, active, and pending proposals, including percent effort and total direct costs (annual), where possible. Include a brief discussion of any potential overlap with the current proposal.

7. Letter(s) of support: Provide a letter of support from the department chair or other unit head. In addition, for junior investigators, department chairs/unit heads should comment on the independence of the applicant and availability of research space and other resources for the proposed research. Include the letter of support at the end of your PDF proposal and address it to the RAP Committee. If there are multiple (two) PIs, a letter of support is required for both PIs. If PIs are in the same department, the chair can vouch for both PIs in a single letter. VIEW SAMPLE